Acuitas activEHR 2.0 will allow Eligible Professionals to meet all necessary obligations and qualify for stimulus funds as per current requirements for either Stage 1 or Stage 2 Meaningful Use, as directed by the ONC and CMS. Certification of Acuitas activEHR 2.0 included use of the DrFirst E-Prescribing platform, as well as Secure Exchange Solutions (SES) technology to demonstrate compliance with all current Meaningful Use requirements. DrFirst provides necessary tools for electronic prescribing of medications and interaction with pharmacies across the US. Secure Exchange Solutions technology is used to share health information and facilitate secure communications between providers, as well as between doctor and patient by way of individualized Patient Portals. Ocuco anticipates that Acuitas activEHR 2.0 will become available to the North American market in the summer of 2015.
Read the Press Release.
Read the Certification details.